Nantkwest

Get Full Access

Description

  • NantKwest (NASDAQ: NK) is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, infectious diseases and inflammatory diseases. NK cells are the bodys first line of defense due to the innate ability of NK cells to rapidly identify and destroy cells under stress, such as cancer or virally-infected cells. NantKwest is uniquely positioned to implement precision cancer medicine, with the potential to change the current paradigm of cancer care. Natural Killer cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. Our off-the-shelf activated Natural Killer (NK) platform have the capacity to destroy cancer and virally infected cells from the body. The safety of our NK cells as well as their activity against a broad range of cancers have been tested in multiple phase 1 clinical trials in the United States, Canada and Europe. In addition to our NK cells capability to be administered in the outpatient setting as an off-the-shelf living drug, it serves as a universal cell-based therapy without need for individualized patient matching. Moreover, our NK cell based platform has been bioengineered to incorporate chimeric antigen receptors (CARs) and antibody receptors to further optimize targeting and potency in the therapeutic disease. Our targeted therapeutic areas include: (1) cancer, focusing on bulky hematological cancers and solid tumors as well as cancer stem cells, (2) infectious diseases, including viral, fungal and bacterial infections, and (3) inflammatory diseases, ranging from rare inherited diseases to more prevalent autoimmune disorders.
  • location

    Headquarters:9920 Jefferson Boulevard , Culver City, California, United States

    More
  • Nantkwest phone

    Phone Number: +1 858-633-0300

  • Nantkwest website

    Website: https://www.nantkwest.com

  • Nantkwest employees

    Employees:71

  • Nantkwest revenue

    Revenue:$50 - 100M

  • Nantkwest legal name

    Legal Name:Nantkwest

  • Nantkwest's Social Media

    Nantkwest linkedin Nantkwest facebook Nantkwest twitter
  • done Is this data correct?
  • |  NAICS Code: 325414  |

    Show More
Person level website identification

Vice President, Financial Planning And Analysis for Nantkwest

James Tzavaras

Vice President, Financial Planning And Analysis

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

James Tzavaras

Vice President, Financial Planning And Analysis

Scott Yuen

Director Of Quality Control

Chris Whittington

Head Of Operations Project Management

Marit Piacente

Head, Pre-Clinical Development

Shaila Tamragouri

Director Of Operations

Frequently Asked Questions regarding Nantkwest

  • Where are Nantkwest's Headquarters?

    Nantkwest's Headquarters are in 9920 Jefferson Boulevard ,Culver City,California,United States

  • What is Nantkwest's phone number?

    Nantkwest's phone number is +1 858-633-0300

  • What is Nantkwest's official website?

    Nantkwest's official website is https://www.nantkwest.com

  • What is Nantkwest's Revenue?

    Nantkwest's revenue is $50 - 100M

  • What is Nantkwest's NAICS code?

    Nantkwest's NAICS code is 325414

  • How many employees are working in Nantkwest

    Nantkwest has 71 employees

  • What is Nantkwest's Industry?

    Nantkwest is in the industry of Biotechnology

  • Who is Nantkwest's Vice President, Financial Planning And Analysis?

    Nantkwest's Vice President, Financial Planning And Analysis is James Tzavaras

Company Directory